Cell Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cell Therapy stocks.

Cell Therapy Stocks Recent News

Date Stock Title
May 13 RNAC Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 11 PROK We're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash Wisely
May 10 PROK ProKidney Corp Reports First Quarter 2024 Financial Results
May 10 RNAC Cartesian Therapeutics Inc (RNAC) Reports Q1 2024 Earnings: A Detailed Financial and ...
May 10 TIL Instil Bio reports Q1 results
May 10 PROK ProKidney reports Q1 results
May 10 PROK ProKidney Reports Business Updates and First Quarter 2024 Financial Results
May 10 TIL Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 9 VCEL Critical Insights From Vericel Analyst Ratings: What You Need To Know
May 9 VCEL Vericel Corporation (NASDAQ:VCEL) Q1 2024 Earnings Call Transcript
May 9 VCEL Vericel First Quarter 2024 Earnings: Beats Expectations
May 9 RNAC Cartesian Therapeutics Reports First Quarter 2024 Earnings
May 9 CGEM Insider Sale at Cullinan Therapeutics Inc (CGEM): Chief Scientific Officer Jennifer Michaelson ...
May 9 VCEL Vericel Corp (VCEL) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...
May 9 VCEL Q1 2024 Vericel Corp Earnings Call
May 8 VCEL Vericel Corporation 2024 Q1 - Results - Earnings Call Presentation
May 8 VCEL Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript
May 8 RNAC Cartesian Therapeutics GAAP EPS of -$10.50, revenue of $5.84M
May 8 VCEL Vericel Corp (VCEL) Surpasses Q1 Revenue Forecasts with Strong Growth in Core Markets
May 8 VCEL Vericel GAAP EPS of -$0.08 beats by $0.03, revenue of $51.3M beats by $2.23M
Cell Therapy

Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Cell therapy originated in the nineteenth century when scientists experimented by injecting animal material in an attempt to prevent and treat illness. Although such attempts produced no positive benefit, further research found in the mid twentieth century that human cells could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation.Today two distinct categories of cell therapy are recognized.The first category is cell therapy in mainstream medicine. This is the subject of intense research and the basis of potential therapeutic benefit. Such research can be controversial when it involves human embryonic material.
The second category is in alternative medicine, and perpetuates the practice of injecting animal materials in an attempt to cure disease. This practice, according to the American Cancer Society, is not backed by any medical evidence of effectiveness, and can have deadly consequences.

Browse All Tags